Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences.

Abstract:

:Leishmaniasis is an infectious disease caused by parasitic flagellates of the genus Leishmania. The authors present a case of 44-year-old man with Crohn's disease treated successfully with infliximab. This case report shows rare visceral leishmaniasis with cutaneous symptoms in an immunocompromised patient. Skin manifestations may occur before or after the visceral infection and they are often diverse.

journal_name

Dermatol Ther

journal_title

Dermatologic therapy

authors

Juzlova K,Votrubova J,Kacerovska D,Lukas M,Bortlik M,Rohacova H,Nohynkova E,Vojackova N,Fialova J,Hercogova J

doi

10.1111/dth.12083

subject

Has Abstract

pub_date

2014-05-01 00:00:00

pages

131-4

issue

3

eissn

1396-0296

issn

1529-8019

journal_volume

27

pub_type

杂志文章
  • Anogenital epidermolytic acanthomas: effective treatment of pruritus with 0.1% tacrolimus ointment.

    abstract::Epidermolytic acanthoma is an uncommon benign tumor with a predilection for the anogenital region, that is characterized histologically by epidermolytic hyperkeratosis. Most reported cases are asymptomatic while some are pruritic. Treatment of this condition is challenging and not well studied. We report a 55-year-old...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.12068

    authors: Tan GF,Tan ES,Tey HL

    更新日期:2014-03-01 00:00:00

  • Pediatric atopic dermatitis: should we treat it differently?

    abstract::Atopic dermatitis is an extremely common childhood skin disease that can have far-reaching impact on patients and families. Pediatric patients, particularly infants, pose special concerns for parents and providers, and equal emphasis must be placed on both nonpharmacologic and prescription interventions. Concerns for ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2006.00061.x

    authors: Sidbury R,Poorsattar S

    更新日期:2006-03-01 00:00:00

  • Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4.

    abstract::In the past decade, the expanded use of targeted anticancer drugs has significantly prolonged survival in patients treated for a variety of cancers. Despite their increased specificity, agents such as epidermal growth factor receptor inhibitors (EGFRIs), BRAF inhibitors, and targeted immunotherapies have commonly been...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.12027

    authors: Fischer A,Rosen AC,Ensslin CJ,Wu S,Lacouture ME

    更新日期:2013-03-01 00:00:00

  • Oral propranolol administration is effective for infantile hemangioma in late infancy: A retrospective cohort study.

    abstract::The highest efficacy of oral propranolol is for infantile hemangioma (IH) in the proliferative phase. Evaluation of the effectiveness of oral propranolol is less established when it is administered in late infancy following the proliferative phase. We aimed to assess the clinical outcomes of pediatric patients managed...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13331

    authors: Kridin K,Pam N,Bergman R,Khamaysi Z

    更新日期:2020-05-01 00:00:00

  • Apatinib-induced Grade 3 hand-foot syndrome in advanced lung adenocarcinoma successful treated with thalidomide: A case report.

    abstract::Hand-foot syndrome (HFS) is a specific cutaneous toxicity caused by a variety of antitumor drugs. The most common drugs include capecitabine, pegylated liposomal doxorubicin and fluorouracil (PLD), tyrosine kinase inhibitor. It is a dose-limiting cutaneous toxicity of these drugs. We reported an advanced lung adenocar...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13241

    authors: Ren Y,Li T,Du LY,Qiu Y,Wang SB,Lei KJ,Jia YM

    更新日期:2020-03-01 00:00:00

  • Drug therapy in pediatrics: a developing field.

    abstract::For many years, drug therapies were not explicitly studied in the pediatric population. The lack of data forced clinicians to treat children using empiric therapy, often guessing at the treatment dose. In addition to the lack of dosing information, there was no evidence that a product would be safe and efficacious in ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2009.01239.x

    authors: Mathis L,Rodriguez W

    更新日期:2009-05-01 00:00:00

  • Cyclosporin in dermatology: A practical compendium.

    abstract::Cyclosporine A (CYA) belongs to calcineurin inhibitor family, which has the ability to selectively suppress T cells. Owing to its immune-modulatory effects, it had been in use for graft vs host diseases and organ transplant rejection for many years, but in dermatology, it was first approved for use in 1997 in the trea...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.13934

    authors: Amber T,Tabassum S

    更新日期:2020-11-01 00:00:00

  • Therapeutic options for chronic hand dermatitis.

    abstract::Hand dermatitis is a common skin condition that often has a chronic and/or relapsing clinical course. Several clinical forms of hand dermatitis have been described, including contact (i.e., allergic and irritant), hyperkeratotic (i.e., psoriasiform or tylotic), frictional, nummular, atopic, pompholyx (i.e., dyshidrosi...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1396-0296.2004.04025.x

    authors: Warshaw EM

    更新日期:2004-01-01 00:00:00

  • Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness.

    abstract::Non-peristomal postoperative pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that occurs in the early postoperative period at surgical incisions, most commonly after breast surgery. Early diagnosis and treatment is essential to prevent severe scaring. TNF-alpha inhibitor infliximab was reported to...

    journal_title:Dermatologic therapy

    pub_type: 信件

    doi:10.1111/dth.12774

    authors: Ariane M,Bouaziz JD,de Masson A,Jachiet M,Bagot M,Lepelletier C

    更新日期:2019-01-01 00:00:00

  • Histological findings after intralesional methotrexate treatment in cutaneous squamous cell carcinoma.

    abstract::Intralesional methotrexate (il-MTX) has been reported as a useful therapy in keratoacanthoma (KA) and cutaneous squamous cell carcinoma (cSCC). However, the data available on the histological changes induced by this therapy are very scarce. We conducted a single center, prospective study that included 65 cases of cSCC...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14377

    authors: Bergón-Sendín M,Parra-Blanco V,Pulido-Pérez A,Nieto-Benito LM,Rosell-Díaz ÁM,Suárez-Fernández R

    更新日期:2020-11-01 00:00:00

  • Self-administered daylight-activated photodynamic therapy for the treatment of hand eczema: A prospective proof-of-concept study.

    abstract::Photodynamic therapy (PDT), traditionally used in patients with nonmelanoma skin cancer, has been found to be effective for various inflammatory skin conditions. Daylight-activated PDT (DL-PDT), in which the sun serves as the light source, is substantially less painful than conventional PDT. This study aimed to determ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14329

    authors: Kremer N,Sherman S,Lapidoth M,Enk CD,Leshem YA,Mimouni T,Dudkiewicz D,Hodak E,Levi A

    更新日期:2020-11-01 00:00:00

  • Classification and evaluation of photodermatoses.

    abstract::Photodermatoses can be classified into five general categories: 1) idiopathic photodermatoses, including polymorphic light eruption (PMLE), actinic prurigo, hyroa vacciniforme, chronic actinic dermatitis, and solar urticaria; 2) photodermatoses which are secondary to exogenous agents, including phototoxic and photoall...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1046/j.1529-8019.2003.01601.x

    authors: Yashar SS,Lim HW

    更新日期:2003-01-01 00:00:00

  • Short- and long-term effects of two emollients on itching and skin restoration in xerotic eczema.

    abstract::Pruritus is associated with various skin diseases, dry skin, and with it an impaired skin barrier function. The study objective was to investigate short-term and long-term effects of two emollients on symptoms and skin barrier functions in xerotic eczema. Randomized, double-blind, study enrolling females/males, with b...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/dth.12692

    authors: Simon D,Nobbe S,Nägeli M,Barysch M,Kunz M,Borelli S,Hasan-Ali O,Wildi E,Gasser UE

    更新日期:2018-11-01 00:00:00

  • Treatment of chronic venous leg ulcers by platelet gel.

    abstract::Chronic venous leg ulcers (CVLU) are chronic wounds, associated with long-standing venous hypertension, which have a poor prognosis for healing. In the process of wound healing the first step is represented by platelet aggregation and subsequent release of growth factors and other mediators, which play a key role in t...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/j.1529-8019.2008.00196.x

    authors: Ficarelli E,Bernuzzi G,Tognetti E,Bussolati O,Zucchi A,Adorni D,De Panfilis G

    更新日期:2008-07-01 00:00:00

  • Cutaneous necrotizing vasculitis: a rational therapeutic approach.

    abstract::Cutaneous necrotizing vasculitis is a heterogeneous group of disorders characterized clinically by palpable purpura, and histologically by a segmental angiocentric inflammatory condition with fibrinoid necrosis of the vessel wall, endothelial swelling, and nuclear dust of the post capillary venules. Often, the skin se...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/j.1529-8019.2012.01480.x

    authors: Tsampau D,Buggiani G,Hercogova J,Lotti T

    更新日期:2012-07-01 00:00:00

  • Timing of quality of life improvements in psoriatic patients treated with different systemic therapies.

    abstract::Psoriasis impacts the quality of life (QoL) by disrupting overall health and social life. Thus, the use of a QoL evaluation item is crucial in assessing a therapeutic regimen. Also, faster improvements in QoL lead to better patient compliance, but very few studies compare psoriasis traditional and biologic therapies t...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13021

    authors: Pistone G,Gurreri R,Tilotta G,Caruso P,Curiale S,Bongiorno MR

    更新日期:2019-09-01 00:00:00

  • Management of chronic pruritus with a UV filtering topical cream.

    abstract::Chronic pruritus is a common dermatological condition affecting 10-13% of the general population. UVB phototherapy has been demonstrated to be effective in relieving the symptoms of pruritus. However, phototherapy is rarely administered because the treatment is time-consuming and expensive, when compared to other topi...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.12309

    authors: Zanardelli M,Kovacevic M,McCoy J,Wang X,Goren A,Lotti T

    更新日期:2016-03-01 00:00:00

  • Evaluating sun protection behaviors and skin self-examination practices among the family members of melanoma patients in Turkey: A cross-sectional survey study.

    abstract::To evaluate the preventive practices in family members of melanoma patients regarding melanoma in Turkey and compare our results with similar studies by a literature review. A questionnaire-based, cross-sectional study was conducted in 52 participants over the age of 18 years. The questionnaire consisted of the items ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14268

    authors: Sarikaya Solak S,Yondem H,Cicin I

    更新日期:2020-11-01 00:00:00

  • Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology.

    abstract::Both in the topical and systemic treatment of psoriasis, retinoids are mainstays. In this chapter the history and modes of actions of retinoids are presented. Tazarotene and acitretin are the only retinoids that are available in both topical and systemic formulations. A more extensive description of their pharmacology...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2006.00082.x

    authors: van de Kerkhof PC

    更新日期:2006-09-01 00:00:00

  • Effect of varicella zoster vaccine vs candida antigen injection in treatment of warts.

    abstract::Treatment of warts is considered as a big challenge for patients as well as doctors. Immunotherapy represents a promising and successful method of warts treatment. A great attention has been paid for various types of immunotherapeutic agents. One of the immunotherapeutic approaches is intralesional immunotherapy that ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14667

    authors: Amer A,Nassar A,Gamal D,Marei A

    更新日期:2020-12-12 00:00:00

  • Successful treatment of porocarcinoma with maxacalcitol and imiquimod.

    abstract::This is the first report of a case of porocarcinoma that was successfully treated with maxacalcitol and imiquimod. ...

    journal_title:Dermatologic therapy

    pub_type: 信件

    doi:10.1111/dth.12830

    authors: Nagasawa T,Hirata A,Niiyama S,Enomoto Y,Fukuda H

    更新日期:2019-03-01 00:00:00

  • A case of Jarisch-Herxheimer reaction in candidiasis treated with systemic fluconazole.

    abstract::Jarisch-Herxheimer reaction (JHR) is an acute and self-limited condition, which commonly occurs after treatment for spirochetal infections. Probably, it corresponds to a transient immunological reaction to endotoxin-like products released from the microorganism during the therapy. For this reason, JHR may be associate...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13244

    authors: Muscianese M,Magri F,Pranteda G,Pranteda G

    更新日期:2020-03-01 00:00:00

  • Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study.

    abstract::Pustulosis palmoplantaris (PPP; synonyms: pustulosis palmaris et plantaris, palmoplantar amicrobic pustulosis) is a common chronic, relapsing, pustular eruption affecting the palms and soles. The authors report the successful treatment of six therapy-experienced patients with histologically confirmed PPP with oral itr...

    journal_title:Dermatologic therapy

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1529-8019.2008.01219.x

    authors: V'lckova-Laskoska MT,Caca-Biljanovska NG,Laskoski DS,Kamberova SJ

    更新日期:2009-01-01 00:00:00

  • Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting.

    abstract::Psoriatic patients with latent tuberculosis infection (LTBI) need a prophylaxis before starting a treatment with biological drugs. The aim of this study is to investigate the safety and efficacy of prophylaxis of LTBI in psoriatic patients receiving long-term biological drugs. The study included 56 patients (42 male a...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.12503

    authors: Conti A,Piaserico S,Gisondi P,Odorici G,Galdo G,Lasagni C,Pellacani G

    更新日期:2017-09-01 00:00:00

  • Topical and oral bexarotene.

    abstract::Bexarotene is a retinoid that specifically binds retinoid X receptors and has numerous effects on cellular growth and differentiation. It is approved for the treatment of cutaneous T cell lymphoma both topically and systemically. Adverse effects include hyperlipidemia, central hypothyroidism, and neutropenia with bexa...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.12087

    authors: Schadt CR

    更新日期:2013-09-01 00:00:00

  • A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg.

    abstract::A change of pricing policy in Spain have made both doses of ustekinumab (UST), 45 and 90 mg, recently available at the same price. Our primary objective was to evaluate effectiveness of UST 90 mg at 52 and 104 weeks in psoriasis patients in clinical practice; secondary objectives were to study the reasons for using th...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13678

    authors: Llamas-Velasco M,Baniandrés O,Rivera R,Reymundo Jimenez A,Hospital M,García Zamora E,González-Cantero Á,Andrés Lencina JJ,Daudén E,de la Cueva P

    更新日期:2020-07-01 00:00:00

  • Improving aseptic injection standards in aesthetic clinical practice.

    abstract::The rise in popularity and demand for nonsurgical injectable aesthetic procedures is inherently accompanied by an increase in reported complications, particularly those related to infection. Aseptic technique is under the control of aesthetic practitioners and can be modified to minimize the potential for cross-contam...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.14416

    authors: Murthy R,Eccleston D,Mckeown D,Parikh A,Shotter S

    更新日期:2020-10-17 00:00:00

  • A comparative study of the effectiveness of cisplatin and 5-fluorouracil on cutaneous squamous human carcinoma cell line: Potential chemotherapy alternative to surgery.

    abstract::Surgery as treatment for local invasive cutaneous squamous cell carcinoma (cSCC) is not always feasible due to the age and/or the health status of patients. Thus, the investigation of new strategies to improve the quality of life of them is required. The aim of this work is to investigate two chemotherapy agents indiv...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.12373

    authors: Gil S,Yébenes M,Luelmo J,Alsina M,Sabés M

    更新日期:2016-09-01 00:00:00

  • Chemical and mechanical characterization of hyaluronic acid hydrogel cross-linked with polyethylen glycol and its use in dermatology.

    abstract::Hydrogels based on hyaluronic acid are used to restore volume, hydration, and skin tone, as well as to correct scars, asymmetries or defects of the soft tissue. Hyaluronic acid is often chemically crosslinked with different crosslinking agents in order to improve its mechanical and biological properties. Here we focus...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13747

    authors: Zerbinati N,Esposito C,Cipolla G,Calligaro A,Monticelli D,Martina V,Golubovic M,Binic I,Sigova J,Gallo AL,D'Este E,Jafferany M,Pratosoni M,Tirant M,Van Thuong N,Sangalli F,Rauso R,Lotti T

    更新日期:2020-07-01 00:00:00

  • Reduced doses of biological therapies in psoriasis may increase efficiency without decreasing drug survival.

    abstract::Off-label treatment with reduced doses of biological therapies for moderate-severe psoriasis is used, but its efficacy, safety, and persistence are not well known. We have compared reduced doses with standard an escalated doses and study predictive factors for a successful reduction of doses lasting more than 6 months...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14134

    authors: Llamas-Velasco M,Daudén E

    更新日期:2020-11-01 00:00:00